New drug tested for Hard-to-Treat thyroid condition

NCT ID NCT05907668

Summary

This study tested whether a drug called batoclimab could help control Graves' disease in adults whose thyroid hormone levels remained too high despite standard medication. Thirty-five participants received batoclimab injections for 24 weeks while researchers monitored their thyroid levels and safety. The goal was to see if this new treatment could help normalize thyroid function, potentially allowing patients to reduce or stop their other medications.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for GRAVES DISEASE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • Site Number - 6505

    Mainz, 55131, Germany

Conditions

Explore the condition pages connected to this study.